ÌÇÐÄvlog´«Ã½

Active and Intelligent Packaging in Pharmaceutical Market Analysis

The Active & Intelligent Packaging in Pharmaceutical Market is expected to grow at a CAGR of 9% over the forecast period 2020 to 2025. With remarkably many data-driven and AI-oriented and trending technologies already influencing the status of the logistics and packaging market, the global pharmaceutical industry gets roped in with them all to produce overall better outcomes. Owing to connectivity and product safety, drug, healthcare, pharmaceutical, and biopharmaceutical organizations are investing a lot in smart packaging solutions. Since temperature and time affect the overall condition of drugs and medicines, the necessity to have an effective and intelligent packaging system is of topmost priority. This is becoming a significant growth driver for the overall pharmaceutical packaging industry.

• Near field communication (NFC) exhibits profitable and tolerable use cases in Pharmaceutical. NFC was required in pharmaceuticals, as a report by the World Health Organization (WHO) in 2019, reveals that even today, counterfeit drugs account for 8-15% of all pharmaceutical and drug products retailed globally. Using NFC, customers can scan for the authentication of products and check their legitimacy, validity, history, and dose instructions before consuming.
• Market demand has been growing for Active & Intelligent Packaging solutions that not only protect products from unwanted moisture and oxygen ingress but also proactively remove moisture and gases within the package headspace, as well as reactive impurities and off-gassing from increasingly sophisticated, costly and valuable OSD products.
• Aptar CSP Technologies has introduced a couple of solutions. For instance, for bottles, Activ-Seal closures feature gas-scavenging and moisture-scavenging technologies built directly into an induction-sealed, tamper-evident screw cap. For blisters, Activ-Blister solutions control each cavity's internal atmosphere, providing desiccant and scavenging capabilities to traditional and existing blistering films and design, negating the need for purging or secondary packaging.
• The Active & Intelligent Packaging in Pharmaceutical Market is, therefore, witnessing a remarkable growth. Advances in printed electronics are boosting the potential opportunities for Active & intelligent packaging by lowering costs. Whereas, significant challenges are rising prices of the pharmaceuticals, lack of willingness from consumers and retailers, and lack of marketing acting as a major restraint for the growth of the market.
• Presently, pharmaceutical businesses are reacting to the prompt challenges resulting from the disruption in supply chains and the necessity to change business processes. If the current COVID-19 pandemic persists for a medium or long time, it may influence the supply of active material and ingredients (mainly from China), as well as the import and export of pharmaceuticals. There is also the potential for contradictory impacts of both a medium and longer-term nature on R&D and manufacturing projects, as well as the delay on projects or programs not related to the core supply chain/data management operations.

Active and Intelligent Packaging in Pharmaceutical Industry Segmentation

Active and intelligent packaging involving ground-breaking technologies such as corrosion control packaging, gas scavengers, susceptor packaging, moisture control packaging, thermochromic ink packaging, time-measured indicators, temperature-oriented indicators, NFC components, QR codes, RFID ICS, and so on. Advancements in active and intelligent packaging technologies are helping to ensure that oral solid dose (OSD) drug delivery - which comprises both capsules and tablets and remains the most popular delivery method.